The effect of anal hygiene method in prevention from recurrent lower urinary tract infections in women

Year 2022, , 1568 - 1571, 25.10.2022

Bılal Günaydın , Sarp Korcan Keskin

https://doi.org/10.32322/jhsm.1163316

Abstract

Aim: To evaluate the effects stopping the use of water and hands on preventing urinary tract infections (UTI) for a group of female patients having recurrent UTIs (rUTI).
Material and Method: A retrospective observational study conducted in a tertiary care hospital between February 2017 and March 2018. 273 female patients which had rUTIs without any concomitant risk factors were included. In the study, 2 or more bacteriologically documented UTIs in the last 6 months were accepted as rUTI. The groups of the study defined as using their hands, using water only and using toilet paper (using either one of these two methods and then using toilet paper). Patients were observed for an average time of 10.4 months after stopping the use of water and hands for anal cleansing after defecation. Instead they were all given toilet education and started wiping for anal hygiene.
Results: There was a statistically significant relationship between previous history of UTI and washing with hands + water (p=0.021). The rate of previous UTIs were significantly higher in the group of patients using their hands for anal washing (69% vs 31%). No relation was found between previous UTI history variable for using toilet paper and flushing with water only (p>0.05). Our results showed a statistically significant decrease of UTIs after stopping the use of water and hands in the patient group who had a previous UTI history (p=0.001).
Conclusion: We managed to underline that washing with hands for anal cleansing as a risk factor for rUTIs in women. Also showed the positive effect of stopping the use of water and hands for anal cleansing after defecation for prevention from rUTIs. We encourage all clinicians for further studies to investigate this issue in the future.

Keywords

Recurrent urinary tract infections, anal cleansing, anal hygiene

References

• Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health 1990; 80: 331-3.
• Albertsen PC. Risk factors for recurrent urinary tract infection in young women. J Urol 2003; 170: 698.
• Aydin A, Ahmed K, Zaman I, Khan MS, Dasgupta P. Recurrent urinary tract infections in women. Int Urogynecol J 2015; 26: 795-804.
• Nickel JC. Practical management of recurrent urinary tract infections in premenopausal women. Rev Urol 2005; 7: 11-7.
• Kodner CM, Thomas Gupton EK. Recurrent urinary tract infections in women: diagnosis and management. Am Fam Physician 2010; 82: 638-43.
• Hickling, DR, Nitti VW. Management of recurrent urinary tract infections in healthy adult women. Rev Urol 2013; 15: 41-8.
• Gupta K., Trautner BW. Diagnosis and management of recurrent urinary tract infections in non-pregnant women. BMJ 2013; 346: f3140.
• Gupta K, Stamm WE. Pathogenesis and management of recurrent urinary tract infections in women. World J Urol 1999; 17: 415-20.
• Eells SJ, Bharadwa K, McKinnell JA. Miller LG. Recurrent urinary tract infections among women: comparative effectiveness of 5 prevention and management strategies using a Markov chain Monte Carlo model. Clin Infect Dis 2014; 58: 147-60.
• Al-Badr A, Al-Shaikh G. Recurrent urinary tract infections management in women: a review. Sultan Qaboos Univ Med 2013; 13: 359-67.
• Guglietta A. Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Microbiol 2017; 12: 239-46.
• Winblad U, Simpson-Hebert M. Ecological Sanitation - Revised and enlarged edition 2004; 67
• Malik RD, Wu YR, Zimmern PE. Definition of recurrent urinary tract infections in women: which one to adopt? Female Pelvic Med Reconstr Surg 2018; 24: 424-9.
• Concia E, Bragantini D, Mazzaferri F. Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections. J Chemother 2017; 29: 19-28.
• Zowawi HM, Harris PN, Roberts MJ, et al. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol 2015; 12: 570-84.
• Bonkat G. Bartoletti RF. Bruyère F, et al. Wullt Guidelines Associates: EAU Guidelines on Urological Infections 2017; 14.
• Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, Stamm WE. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 2000; 30: 152-6.
• Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753-6.
• Naber KG, Cho YH, Matsumoto T, Schaeffer AJ. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents 2009; 33: 111-9.
• Wagenlehner FM, Vahlensieck W, Bauer HW, et al. Prevention of recurrent urinary tract infections. Minerva Urol Nefrol 2013; 65: 9-20.
• Sarikaya K, Senocak C, Ibis MA, Sadioglu FE, Ciftci M, Bozkurt OF. The effect of bladder pain syndrome/interstitial cystitis on partner sexual functions. J Ist Faculty Med 2022; 85: 110-6.